Quantification of rabeprazole in human plasma by liquid chromatography-tandem mass spectrometry

被引:37
作者
Zhang, Y [1 ]
Chen, XY [1 ]
Gu, Q [1 ]
Zhong, DF [1 ]
机构
[1] Shenyang Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Shenyang 110016, Peoples R China
关键词
liquid chromatography-tandent mass spectrometry; rabeprazole; human plasma;
D O I
10.1016/j.aca.2004.07.023
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
An analytical method based on liquid chromatography coupled with tandem mass spectrometry detection has been developed and validated for the determination of rabeprazole in human plasma using omeprazole as the internal standard. The analyte and internal standard was extracted with n-hexane-dichloromethane-isopropanol (20:10:1, v/v) and chromatographed isocratically on a Diamonsil C-18 analytical column. Methanol was used as the mobile phase to avoid decomposition of rabeprazole. The drug was detected in the selected reaction monitoring mode using an atmospheric pressure chemical ionization source. The method was linear within the range 2.0-800ng/ml. The lower limit of quantification was 2.0 ng/ml. The intra- and inter-day precision, calculated from quality control (QC) samples, was less than 9.8%. The accuracy was within 1.1 %. The method herein described was employed in a pharmacokinetic study after an oral administration of 20 mg rabeprazole to 18 healthy volunteers. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 8 条
[1]   Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products [J].
El-Gindy, A ;
El-Yazby, F ;
Maher, MM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (02) :229-242
[2]   Plasma direct injection high-performance liquid chromatographic method for simultaneously determining E3810 enantiomers and their metabolites by using flavoprotein-conjugated column [J].
Mano, N ;
Oda, Y ;
Takakuwa, S ;
Chiku, S ;
Nakata, H ;
Asakawa, N .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (09) :903-907
[3]   DETERMINATION OF A NEW H+-K+ ATPASE INHIBITOR (E3810) AND ITS 4 METABOLITES IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
NAKAI, H ;
SHIMAMURA, Y ;
KANAZAWA, T ;
YASUDA, S ;
KAYANO, M .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 660 (01) :211-220
[4]  
Nochi S, 1996, CHEM PHARM BULL, V44, P552
[5]   Rabeprazole [J].
Prakash, A ;
Faulds, D .
DRUGS, 1998, 55 (02) :261-267
[6]   Proton pump inhibitors - Pharmacology and rationale for use in gastrointestinal disorders [J].
Richardson, P ;
Hawkey, CJ ;
Stack, WA .
DRUGS, 1998, 56 (03) :307-335
[7]  
SACHS G, 1995, ANNU REV PHARMACOL, V35, P277, DOI 10.1146/annurev.pa.35.040195.001425
[8]   ENANTIOSELECTIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR DETERMINATION OF THE ENANTIOMERS OF A NEW ANTIULCER AGENT, E3810, IN BEAGLE DOG PLASMA AND RAT PLASMA [J].
TAKAKUWA, S ;
CHIKU, S ;
NAKATA, H ;
YUZURIHA, T ;
MANO, N ;
ASAKAWA, N .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 673 (01) :113-122